Molecular Oncology
Volume 1, Issue 2 , Pages 144-159 , September 2007

Cancer proteomics by quantitative shotgun proteomics

Received 22 March 2007 ,Revised 30 April 2007 ,Accepted 1 May 2007.

References 

  1. Abe Y, Chaen T, Jin XR, Hamasaki T, Hamasaki N. Mass spectrometric analyses of transmembrane proteins in human erythrocyte membrane. J. Biochem. (Tokyo). 2004;136:97–106
  2. Aggarwal K, Choe LH, Lee KH. Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct. Genomic Proteomic. 2006;5:112–120
  3. Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat. Genet. 2003;34:369–376
  4. Amanchy R, Kalume DE, Iwahori A, Zhong J, Pandey A. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). J. Proteome Res. 2005;4:1661–1671
  5. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics. 2006;5:573–588
  6. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics. 2002;1:845–867
  7. Anderson NL, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics. 2004;3:311–326
  8. Baker H, et al. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry. Oral Oncol. 2005;41:183–199
  9. Bantscheff M, Dumpelfeld B, Kuster B. Femtomol sensitivity post-digest (18)O labeling for relative quantification of differential protein complex composition. Rapid Commun. Mass Spectrom. 2004;18:869–876
  10. Barr JR, et al. Isotope dilution–mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin. Chem. 1996;42:1676–1682
  11. Beausoleil SA, Villen J, Gerber SA, Rush J, Gygi SP. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 2006;24:1285–1292
  12. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat. Rev. Mol. Cell. Biol. 2003;4:915–925
  13. Blonder J, Goshe MB, Moore RJ, Pasa-Tolic L, Masselon CD, Lipton MS, et al. Enrichment of integral membrane proteins for proteomic analysis using liquid chromatography-tandem mass spectrometry. J. Proteome Res. 2002;1:351–360
  14. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer. 2004;4:793–805
  15. Bottari P, Aebersold R, Turecek F, Gelb MH. Design and synthesis of visible isotope-coded affinity tags for the absolute quantification of specific proteins in complex mixtures. Bioconjug. Chem. 2004;15:380–388
  16. Boudreau N, Bissell MJ. Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr. Opin. Cell. Biol. 1998;10:640–646
  17. Brill LM, Salomon AR, Ficarro SB, Mukherji M, Stettler-Gill M, Peters EC. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal. Chem. 2004;76:2763–2772
  18. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 1998;58:1408–1416
  19. Buchanan NS, Hamler RL, Leopold PE, Miller FR, Lubman DM. Mass mapping of cancer cell lysates using two-dimensional liquid separations, electrospray-time of flight-mass spectrometry, and automated data processing. Electrophoresis. 2005;26:248–256
  20. Bykova NV, Stensballe A, Egsgaard H, Jensen ON, Moller IM. Phosphorylation of formate dehydrogenase in potato tuber mitochondria. J. Biol. Chem. 2003;278:26021–26030
  21. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, et al. Oncogenes and signal transduction. Cell. 1991;64:281–302(published erratum appears in Cell 1991 May 31;65(5):following 914)
  22. Chalmers MJ, Quinn JP, Blakney GT, Emmett MR, Mischak H, Gaskell SJ, et al. Liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometric characterization of protein kinase C phosphorylation. J. Proteome Res. 2003;2:373–382
  23. Chaurand P, Norris JL, Cornett DS, Mobley JA, Caprioli RM. New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry. J. Proteome Res. 2006;5:2889–2900
  24. Chaurand P, Stoeckli M, Caprioli RM. Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry. Anal. Chem. 1999;71:5263–5270
  25. Chen EI, Florens L, Axelrod FT, Monosov E, Barbas CF, Yates JR, et al. Maspin alters the carcinoma proteome. FASEB J. 2005;19:1123–1124
  26. Chen R, et al. Quantitative proteomic profiling of pancreatic cancer juice. Proteomics. 2006;6:3871–3879
  27. Chi A, et al. Analysis of phosphorylation sites on proteins from Saccharomyces cerevisiae by electron transfer dissociation (ETD) mass spectrometry. Proc. Natl. Acad. Sci. USA. 2007;104:2193–2198
  28. Clarke W, Zhang Z, Chan DW. The application of clinical proteomics to cancer and other diseases. Clin. Chem. Lab. Med. 2003;41:1562–1570
  29. Comuzzi B, Sadar MD. Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer. Cell Sci. 2006;3:61–81
  30. Conrads TP, et al. Quantitative analysis of bacterial and mammalian proteomes using a combination of cysteine affinity tags and 15N-metabolic labeling. Anal. Chem. 2001;73:2132–2139
  31. de Noo ME, Tollenaar RA, Deelder AM, Bouwman LH. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears. World J. Gastroenterol. 2006;12:6594–6601
  32. Desiderio DM, Kai M. Preparation of stable isotope-incorporated peptide internal standards for field desorption mass spectrometry quantification of peptides in biologic tissue. Biomed. Mass Spectrom. 1983;10:471–479
  33. DeSouza L, Diehl G, Rodrigues MJ, Guo J, Romaschin AD, Colgan TJ, et al. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 2005;4:377–386
  34. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science. 2006;312:212–217
  35. Du Y, Parks BA, Sohn S, Kwast KE, Kelleher NL. Top-down approaches for measuring expression ratios of intact yeast proteins using Fourier transform mass spectrometry. Anal. Chem. 2006;78:686–694
  36. Dunne A, O'Neill L. New insights into the post-translational modification of Toll-like receptor signaling molecules. J. Endotoxin Res. 2005;11:325–332
  37. Eibl G, Reber HA. A xenograft nude mouse model for perineural invasion and recurrence in pancreatic cancer. Pancreas. 2005;31:258–262
  38. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994;5:976–989
  39. Everley PA, Krijgsveld J, Zetter BR, Gygi SP. Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol. Cell. Proteomics. 2004;3:729–735
  40. Fang R, et al. Differential label-free quantitative proteomic analysis of Shewanella oneidensis cultured under aerobic and suboxic conditions by accurate mass and time tag approach. Mol. Cell. Proteomics. 2006;5:714–725
  41. Florens L, et al. A proteomic view of the Plasmodium falciparum life cycle. Nature. 2002;419:520–526
  42. Florens L, Carozza MJ, Swanson SK, Fournier M, Coleman MK, Workman JL, et al. Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors. Methods. 2006;40:303–311
  43. Gao J, Opiteck GJ, Friedrichs MS, Dongre AR, Hefta SA. Changes in the protein expression of yeast as a function of carbon source. J. Proteome Res. 2003;2:643–649
  44. Garcia BA, et al. Comprehensive phosphoprotein analysis of linker histone H1 from Tetrahymena thermophila. Mol. Cell. Proteomics. 2006;5:1593–1609
  45. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA. 2003;100:6940–6945
  46. Gill G. Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr. Opin. Genet. Dev. 2003;13:108–113
  47. Goldberg AL. Functions of the proteasome: the lysis at the end of the tunnel. Science. 1995;268:522–523
  48. Gorg A, Weiss W, Dunn MJ. Current two-dimensional electrophoresis technology for proteomics. Proteomics. 2004;4:3665–3685
  49. Goshe MB, Smith RD. Stable isotope-coded proteomic mass spectrometry. Curr. Opin. Biotechnol. 2003;14:101–109
  50. Gronborg M, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics. 2006;5:157–171
  51. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999;17:994–999
  52. Hager JW, Yves Le Blanc JC. Product ion scanning using a Q-q-Q linear ion trap (Q TRAP) mass spectrometer. Rapid Commun. Mass Spectrom. 2003;17:1056–1064
  53. Hamdan M, Righetti PG. Assessment of protein expression by means of 2-D gel electrophoresis with and without mass spectrometry. Mass Spectrom. Rev. 2003;22:272–284
  54. Hara T, Honda K, Shitashige M, Ono M, Matsuyama H, Naito K, et al. Mass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells. Mol. Cell. Proteomics. 2007;6:479–491
  55. Hendrix MJ. De-mystifying the mechanism(s) of maspin (news). Nat. Med. 2000;6:374–376
  56. Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr. Opin. Cell. Biol. 1997;9:788–799
  57. Hondermarck H. Breast cancer: when proteomics challenges biological complexity. Mol. Cell. Proteomics. 2003;2:281–291
  58. Howell KE, Palade GE. Hepatic Golgi fractions resolved into membrane and content subfractions. J. Cell. Biol. 1982;92:822–832
  59. Hu S, Loo JA, Wong DT. Human saliva proteome analysis. Ann. N.Y. Acad. Sci. 2007;1098:323–329
  60. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics. 2005;4:1265–1272
  61. Ishihama Y, Sato T, Tabata T, Miyamoto N, Sagane K, Nagasu T, et al. Quantitative mouse brain proteomics using culture-derived isotope tags as internal standards. Nat. Biotechnol. 2005;23:617–621
  62. Johnson ES, Blobel G. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 1997;272:26799–26802
  63. Johnson ES, Schwienhorst I, Dohmen RJ, Blobel G. The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J. 1997;16:5509–5519
  64. Kaiser P, Huang L. Global approaches to understanding ubiquitination. Genome Biol. 2005;6:233
  65. Kalkum M, Lyon GJ, Chait BT. Detection of secreted peptides by using hypothesis-driven multistage mass spectrometry. Proc. Natl. Acad. Sci. USA. 2003;100:2795–2800
  66. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000;18:621–663
  67. Kelleher NL, Hicks LM. Contemporary mass spectrometry for the direct detection of enzyme intermediates. Curr. Opin. Chem. Biol. 2005;9:424–430
  68. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002;74:5383–5392
  69. Keshamouni VG, et al. Differential protein expression profiling by iTRAQ-2DLC–MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J. Proteome Res. 2006;5:1143–1154
  70. Khalili P, Arakelian A, Chen G, Singh G, Rabbani SA. Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer. Oncogene. 2005;24:6657–6666
  71. Khatib-Shahidi S, Andersson M, Herman JL, Gillespie TA, Caprioli RM. Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry. Anal. Chem. 2006;78:6448–6456
  72. King RW, Deshaies RJ, Peters JM, Kirschner MW. How proteolysis drives the cell cycle. Science. 1996;274:1652–1659
  73. Kjeldsen F, Haselmann KF, Budnik BA, Sorensen ES, Zubarev RA. Complete characterization of posttranslational modification sites in the bovine milk protein PP3 by tandem mass spectrometry with electron capture dissociation as the last stage. Anal. Chem. 2003;75:2355–2361
  74. Klammer AA, MacCoss MJ. Effects of modified digestion schemes on the identification of proteins from complex mixtures. J. Proteome Res. 2006;5:695–700
  75. Kluger HM, Chelouche Lev D, Kluger Y, McCarthy MM, Kiriakova G, Camp RL, et al. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. Cancer Res. 2005;65:5578–5587
  76. Larmann JP, Lemmo AV, Moore AW, Jorgenson JW. Two-dimensional separations of peptides and proteins by comprehensive liquid chromatography-capillary electrophoresis. Electrophoresis. 1993;14:439–447
  77. Lee H, Griffin TJ, Gygi SP, Rist B, Aebersold R. Development of a multiplexed microcapillary liquid chromatography system for high-throughput proteome analysis. Anal. Chem. 2002;74:4353–4360
  78. Lee HJ, Lee EY, Kwon MS, Paik YK. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Curr. Opin. Chem. Biol. 2006;10:42–49
  79. Lemmel C, Weik S, Eberle U, Dengjel J, Kratt T, Becker HD, et al. Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling. Nat. Biotechnol. 2004;22:450–454
  80. Levander F, Rognvaldsson T, Samuelsson J, James P. Automated methods for improved protein identification by peptide mass fingerprinting. Proteomics. 2004;4:2594–2601
  81. Li XJ, Zhang H, Ranish JA, Aebersold R. Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal. Chem. 2003;75:6648–6657
  82. Lin WT, et al. Multi-Q: a fully automated tool for multiplexed protein quantitation. J. Proteome Res. 2006;5:2328–2338
  83. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, et al. Direct analysis of protein complexes using mass spectrometry. Nat. Biotechnol. 1999;17:676–682
  84. Listgarten J, Emili A. Statistical and computational methods for comparative proteomic profiling using liquid chromatography-tandem mass spectrometry. Mol. Cell. Proteomics. 2005;4:419–434
  85. Liu H, Lin D, Yates JR. Multidimensional separations for protein/peptide analysis in the post-genomic era. Biotechniques. 2002;32:898, 900, 902 passim
  86. Liu H, Sadygov RG, Yates JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004;76:4193–4201
  87. Liu T, et al. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol. Cell. Proteomics. 2006;5:2167–2174
  88. Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA. 1999;96:14694–14699
  89. Lu Y, Bottari P, Turecek F, Aebersold R, Gelb MH. Absolute quantification of specific proteins in complex mixtures using visible isotope-coded affinity tags. Anal. Chem. 2004;76:4104–4111
  90. MacCoss MJ, Wu CC, Liu H, Sadygov R, Yates JR. A correlation algorithm for the automated quantitative analysis of shotgun proteomics data. Anal. Chem. 2003;75:6912–6921
  91. Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 2005;382:669–678
  92. McAlhany SJ, Ressler SJ, Larsen M, Tuxhorn JA, Yang F, Dang TD, et al. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. Cancer Res. 2003;63:5859–5865
  93. McDonald WH, Ohi R, Miyamoto DT, Mitchison TJ, Yates JR. Comparison of three directly coupled HPLC MS/MS strategies for identification of proteins from complex mixtures: single-dimension LC–MS/MS, 2-phase MudPIT, and 3-phase MudPIT. Int. J. Mass Spectrom. 2002;219:245–251
  94. Meehan KL, Sadar MD. Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry. Proteomics. 2004;4:1116–1134
  95. Mikesh LM, Ueberheide B, Chi A, Coon JJ, Syka JE, Shabanowitz J, et al. The utility of ETD mass spectrometry in proteomic analysis. Biochim. Biophys. Acta. 2006;1764:1811–1822
  96. Motoyama A, Venable JD, Ruse CI, Yates JR. Automated ultra-high-pressure multidimensional protein identification technology (UHP-MudPIT) for improved peptide identification of proteomic samples. Anal. Chem. 2006;78:5109–5118
  97. Motoyama A, Xu T, Ruse CI, Wohlschlegel JA, Yates JR. Anion and cation mixed-bed ion exchange for enhanced multidimensional separations of peptides and phosphopeptides. Anal. Chem. 2007;79(10):3623–3634
  98. Moulder R, et al. A comparative evaluation of software for the analysis of liquid chromatography-tandem mass spectrometry data from isotope coded affinity tag experiments. Proteomics. 2005;5:2748–2760
  99. Mukhopadhyay D, Riezman H. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science. 2007;315:201–205
  100. Nesvizhskii AI, Aebersold R. Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS. Drug Discov. Today. 2004;9:173–181
  101. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003;75:4646–4658
  102. Normanno N, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366:2–16
  103. Oda Y, Huang K, Cross FR, Cowburn D, Chait BT. Accurate quantitation of protein expression and site-specific phosphorylation. Proc. Natl. Acad. Sci. USA. 1999;96:6591–6596
  104. Oda Y, Nagasu T, Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 2001;19:379–382
  105. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006;127:635–648
  106. Ong SE, Kratchmarova I, Mann M. Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). J. Proteome Res. 2003;2:173–181
  107. Opiteck GJ, Jorgenson JW. Two-dimensional SEC/RPLC coupled to mass spectrometry for the analysis of peptides. Anal. Chem. 1997;69:2283–2291
  108. Orlowski RZ. The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Diff. 1999;6:303–313
  109. Osborne CK, Hobbs K, Trent JM. Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res. Treat. 1987;9:111–121
  110. Pan C, et al. ProRata: a quantitative proteomics program for accurate protein abundance ratio estimation with confidence interval evaluation. Anal. Chem. 2006;78:7121–7131
  111. Pang JX, Ginanni N, Dongre AR, Hefta SA, Opitek GJ. Biomarker discovery in urine by proteomics. J. Proteome Res. 2002;1:161–169
  112. Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, et al. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer. 2006;6:68
  113. Pemberton PA, Wong DT, Gibson HL, Kiefer MC, Fitzpatrick PA, Sager R, et al. The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin. J. Biol. Chem. 1995;270:15832–15837
  114. Peng J, et al. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 2003;21:921–926
  115. Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC–MS/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2003;2:43–50
  116. Pesavento JJ, Mizzen CA, Kelleher NL. Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4. Anal. Chem. 2006;78:4271–4280
  117. Pieper R, Su Q, Gatlin CL, Huang ST, Anderson NL, Steiner S. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics. 2003;3:422–432
  118. Qian WJ, Jacobs JM, Liu T, Camp DG, Smith RD. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol. Cell. Proteomics. 2006;5:1727–1744
  119. Qiu Y, Sousa EA, Hewick RM, Wang JH. Acid-labile isotope-coded extractants: a class of reagents for quantitative mass spectrometric analysis of complex protein mixtures. Anal. Chem. 2002;74:4969–4979
  120. Resing KA, et al. Improving reproducibility and sensitivity in identifying human proteins by shotgun proteomics. Anal. Chem. 2004;76:3556–3568
  121. Reyzer ML, Caprioli RM. MALDI mass spectrometry for direct tissue analysis: a new tool for biomarker discovery. J. Proteome Res. 2005;4:1138–1142
  122. Righetti PG, et al. Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches. J. Chromatogr. A. 2004;1051:3–17
  123. Roelofsen H, Alvarez-Llamas G, Schepers M, Landman K, Vonk RJ. Proteomics profiling of urine with surface enhanced laser desorption/ionization time of flight mass spectrometry. Proteome Sci. 2007;5:2
  124. Rush J, et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 2005;23:94–101
  125. Sadygov RG, Cociorva D, Yates JR. Large-scale database searching using tandem mass spectra: looking up the answer in the back of the book. Nat. Methods. 2004;1:195–202
  126. Sadygov RG, Maroto FM, Huhmer AF. ChromAlign: a two-step algorithmic procedure for time alignment of three-dimensional LC-MS chromatographic surfaces. Anal. Chem. 2006;78:8207–8217
  127. Salomon AR, et al. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc. Natl. Acad. Sci. USA. 2003;100:443–448
  128. Schwartz JC, Senko MW, Syka JE. A two-dimensional quadrupole ion trap mass spectrometer. J. Am. Soc. Mass Spectrom. 2002;13:659–669
  129. Seo J, Lee KJ. Post-translational modifications and their biological functions: proteomic analysis and systematic approaches. J. Biochem. Mol. Biol. 2004;37:35–44
  130. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ, Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl. Acad. Sci. USA. 1996;93:11669–11674
  131. Siuti N, Roth MJ, Mizzen CA, Kelleher NL, Pesavento JJ. Gene-specific characterization of human histone H2B by electron capture dissociation. J. Proteome Res. 2006;5:233–239
  132. Smolka MB, Zhou H, Purkayastha S, Aebersold R. Optimization of the isotope-coded affinity tag-labeling procedure for quantitative proteome analysis. Anal. Biochem. 2001;297:25–31
  133. Stewart JJ, White JT, Yan X, Collins S, Drescher CW, Urban ND, et al. Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol. Cell. Proteomics. 2006;5:433–443
  134. Syka JE, et al. Novel linear quadrupole ion trap/FT mass spectrometer: performance characterization and use in the comparative analysis of histone H3 post-translational modifications. J. Proteome Res. 2004;3:621–626
  135. Sze SK, Ge Y, Oh H, McLafferty FW. Top-down mass spectrometry of a 29-kDa protein for characterization of any posttranslational modification to within one residue. Proc. Natl. Acad. Sci. USA. 2002;99:1774–1779
  136. Tabb DL, McDonald WH, Yates JR. DTASelect and Contrast: tools for assembling and comparing protein identification from shotgun proteomics. J. Proteome Res. 2002;1:21–26
  137. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol. 2006;12:192–198
  138. Thomas CE, Kelleher NL, Mizzen CA. Mass spectrometric characterization of human histone H3: a bird's eye view. J. Proteome Res. 2006;5:240–247
  139. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res. 2002;62:6021–6025
  140. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis. 1997;18:2071–2077
  141. Venable JD, Dong MQ, Wohlschlegel J, Dillin A, Yates JR. Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat. Methods. 2004;1:39–45
  142. Vogt PK, Jiang H, Aoki M. Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle. 2005;4:908–913
  143. Voorhees PM, Dees EC, O'Neil B, Orlowski RZ. The proteasome as a target for cancer therapy. Clin. Cancer Res. 2003;9:6316–6325
  144. Wall DB, Kachman MT, Gong S, Hinderer R, Parus S, Misek DE, et al. Isoelectric focusing nonporous RP HPLC: a two-dimensional liquid-phase separation method for mapping of cellular proteins with identification using MALDI-TOF mass spectrometry. Anal. Chem. 2000;72:1099–1111
  145. Wang G, Wu WW, Pisitkun T, Hoffert JD, Knepper MA, Shen RF. Automated quantification tool for high-throughput proteomics using stable isotope labeling and LC-MSn. Anal. Chem. 2006;78:5752–5761
  146. Wang W, et al. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 2003;75:4818–4826
  147. Washburn MP, Ulaszek R, Deciu C, Schieltz DM, Yates JR. Analysis of quantitative proteomic data generated via multidimensional protein identification technology. Anal. Chem. 2002;74:1650–1657
  148. Washburn MP, Wolters D, Yates JR. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001;19:242–247
  149. Wei J, Sun J, Yu W, Jones A, Oeller P, Keller M, et al. Global proteome discovery using an online three-dimensional LC–MS/MS. J. Proteome Res. 2005;4:801–808
  150. Weinstein IB, Joe AK. Mechanisms of disease: oncogene addiction–a rationale for molecular targeting in cancer therapy. Nat. Clin. Pract. Oncol. 2006;3:448–457
  151. Wienkoop S, Weckwerth W. Relative and absolute quantitative shotgun proteomics: targeting low-abundance proteins in Arabidopsis thaliana. J. Exp. Bot. 2006;57:1529–1535
  152. Wohlschlegel JA, Johnson ES, Reed SI, Yates JR. Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol. Chem. 2004;279:45662–45668
  153. Wolters AD, Washburn MP, Yates JR. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 2001;73:5683–5690
  154. Wu CC, MacCoss MJ, Howell KE, Matthews DE, Yates JR. Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal. Chem. 2004;76:4951–4959
  155. Xu BJ, Caprioli RM, Sanders ME, Jensen RA. Direct analysis of laser capture microdissected cells by MALDI mass spectrometry. J. Am. Soc. Mass Spectrom. 2002;13:1292–1297
  156. Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer. 2001;37(Suppl. 4):S3–S8
  157. Yates JR, Cociorva D, Liao L, Zabrouskov V. Performance of a linear ion trap-Orbitrap hybrid for peptide analysis. Anal. Chem. 2006;78:493–500
  158. Yates JR, Speicher S, Griffin PR, Hunkapiller T. Peptide mass maps: a highly informative approach to protein identification. Anal. Biochem. 1993;214:397–408
  159. Yocum AK, Busch CM, Felix CA, Blair IA. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations. J. Proteome Res. 2006;5:2743–2753
  160. Yoo C, Patwa TH, Kreunin P, Miller FR, Huber CG, Nesvizhskii AI, et al. Comprehensive analysis of proteins of pH fractionated samples using monolithic LC/MS/MS, intact MW measurement and MALDI-QIT-TOF MS. J. Mass Spectrom. 2007;42:312–314
  161. Yoshida K, Sorimachi Y, Fujiwara M, Hironaka K. Calpain is implicated in rat myocardial injury after ischemia or reperfusion. Jpn. Circ. J. 1995;59:40–48
  162. Zang L, Palmer Toy D, Hancock WS, Sgroi DC, Karger BL. Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J. Proteome Res. 2004;3:604–612
  163. Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat. Med. 2000;6:196–199
  164. Zhou H, Boyle R, Aebersold R. Quantitative protein analysis by solid phase isotope tagging and mass spectrometry. Methods Mol. Biol. 2004;261:511–518
  165. Zhu H, Pan S, Gu S, Bradbury EM, Chen X. Amino acid residue specific stable isotope labeling for quantitative proteomics. Rapid Commun. Mass. Spectrom. 2002;16:2115–2123
  166. Zieske LR. A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J. Exp. Bot. 2006;57:1501–1508
  167. Zybailov B, Coleman MK, Florens L, Washburn MP. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal. Chem. 2005;77:6218–6224

PII: S1574-7891(07)00032-4

doi: 10.1016/j.molonc.2007.05.001

Molecular Oncology
Volume 1, Issue 2 , Pages 144-159 , September 2007

Article Tools

* Image Usage & Resolution